Recombinant Human TRIM22 Protein, N-His
文献支持

Recombinant Human TRIM22 Prote

in, N-His
收藏
  • ¥1268
  • abinScience
  • China
  • HC134012
  • 2025年11月12日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

    • 保质期

      1 year

    • 英文名

      Recombinant Human TRIM22 Protein, N-His

    • 库存

      999

    • 供应商

      abinScience

    • 规格

      100ug

    Recombinant Human TRIM22 Prote

    Product nameRecombinant Human TRIM22 Protein, N-His
    Catalog No.HC134012
    Host species\
    Species reactivity\
    Immunogen\
    FormLyophilized
    Storage bufferLyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
    Purity>90% as determined by SDS-PAGE.
    Clonality\
    Isotype\
    ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
    Target\
    Purification\
    Endotoxin levelPlease contact with the lab for this information.
    Expression systemE. coli

    abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.

     

    Technology and Innovation

    Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for ab...

     

    Product categories and application fields.

    Main products.
    10000+ high-activity proteins.
    15000+ antibody series products:
    Classic monoclonal antibody.
    Monoclonal antibody
    Internal control antibody, labeled antibody.
    High-quality phosphorylation antibodies.
    Highly specific nanobodies and small molecule antibodies.
    Functional antibodies in vivo.
    Low-background flow cytometry antibodies.
    DNA/RNA antibodies and PEG antibodies.
    1000+ reagent kit series products.
    Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.


    Application field

    Infectious disease research: including viruses, superbugs, parasites, etc.
    Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
    Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
    Oncology research: Supporting the development of tumor biology and anti-tumor drugs.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    A biocompatible Ag NP/SA.GL hydrogel for enhanced delivery and sustained release of doxorubicin in cancer treatment. (J Biomater Sci Polym Ed, 2025 Nov 9) | Ecological strategies of evergreen and deciduous woody species: including nitrogen and phosphorus allocation among organs, and element-based network. (Oecologia, 2025 Nov 9) | NPCDR 2.0: the activity and structure landscape of natural product-based drug combination. (Nucleic Acids Res, 2025 Nov 8) | Genome insights into the Bacillus paramycoides RZ3MS14: a multi-trait plant growth-promoting rhizobacterium from Amazonian rainforest able to improve the sugarcane growth. (FEMS Microbiol Lett, 2025 Nov 7) | Trends in Global Musculoskeletal Rehabilitation Needs from 1990 to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021. (Arch Phys Med Rehabil, 2025 Nov 6)
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥500
    北京百奥创新科技有限公司
    2025年07月13日询价
    ¥1380
    湖北艾普蒂生物工程有限公司
    2025年07月13日询价
    询价
    缔码生物科技(武汉)有限公司
    2025年07月15日询价
    ¥1868
    普健生物(武汉)科技有限公司
    2025年07月11日询价
    文献支持
    Recombinant Human TRIM22 Protein, N-His
    ¥1268